Intratumoral α-SMA Enhances the Prognostic Potency of CD34 Associated with Maintenance of Microvessel Integrity in Hepatocellular Carcinoma and Pancreatic Cancer

• Wen-Quan Wang ,

  Contributed equally to this work with: Wen-Quan Wang, Liang Liu, Hua-Xiang Xu, Guo-Pei Luo

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Liang Liu ,

  Contributed equally to this work with: Wen-Quan Wang, Liang Liu, Hua-Xiang Xu, Guo-Pei Luo

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Hua-Xiang Xu ,

  Contributed equally to this work with: Wen-Quan Wang, Liang Liu, Hua-Xiang Xu, Guo-Pei Luo

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Guo-Pei Luo ,

  Contributed equally to this work with: Wen-Quan Wang, Liang Liu, Hua-Xiang Xu, Guo-Pei Luo

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Tao Chen,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Chun-Tao Wu,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Yong-Feng Xu,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Jin Xu,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Chen Liu,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Bo Zhang,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Jiang Long,

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯
• Zhao-You Tang,

  Affiliation Liver Cancer Institute, Zhongshan Hospital, Fudan University, Key Laboratory for Carcinogenesis & Cancer Invasion, Chinese Ministry of Education, Shanghai, China

  ⨯
• Xian-Jun Yu

  * E-mail: yuxianjun88@hotmail.com

  Affiliation Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University; and Pancreatic Cancer Institute, Fudan University, Shanghai, China

  ⨯